Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Strength: 1,000 mcg
Aflibercept ranks among the highest-spending drugs in the CMS Medicare Part B Drug Spending Dashboard, with annual Part B spending topping $1 billion, reflecting how often retina practices administer intravitreal anti-VEGF injections
Duration: Preclinical studies have lasted about 4 weeks on average
Inventory and Training Update digital inventory immediately after opening a new lot of 5-Amino-1MQ Peptide
US$ 22.30
US$ 22.33
US$ 23.16
US$ 28.60
US$ 27.05
US$ 22.65
US$ 27.94
